SCHEMBL22190488

SCHEMBL22190488

CCOC(=O)CC(=O)CCCCCC(C)(C)C(=O)OCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.61
CYP4A11 Q02928 2/20 0.61
GAA P10253 2/20 0.46
HTT P42858 1/20 0.44
MGAM O43451 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
PKM P14618 2/20 0.41
THRB P10828 1/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP1A2 P05177 1/20 0.36
ALDH1A1 P00352 2/20 0.35
CYP3A4 P08684 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3279755 0.89 CYP4F2 (0.71) CYP4F2CYP4A11GAAHTTPKM
SCHEMBL31108899 0.89 CYP4F2 (0.71) CYP4F2CYP4A11GAAHTTPKM
SCHEMBL186368 0.89 CYP4F2 (0.71) CYP4F2CYP4A11GAAHTTPKM
SCHEMBL187113 0.89 CYP4F2 (0.71) CYP4F2CYP4A11GAAHTTPKM
SCHEMBL22190528 0.88 CYP4F2 (0.63) CYP4F2CYP4A11GAAHTTMGAM
SCHEMBL14890704 0.87 CYP4F2 (0.69) CYP4F2CYP4A11GAAHTTMGAM
SCHEMBL14809522 0.87 CYP4F2 (0.69) CYP4F2CYP4A11GAAHTTMGAM
SCHEMBL185905 0.87 CYP4F2 (0.68) CYP4F2CYP4A11GAAHTTPKM
SCHEMBL31108865 0.86 CYP4F2 (0.63) CYP4F2CYP4A11GAAHTTPKM
SCHEMBL22193467 0.85 GAA (0.50) CYP4F2CYP4A11GAAHTTMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220081385-A1 NOVEL SALTS AND POLYMORPHIC FORM OF BEMPEDOIC ACID LUPIN LIMITED (IN) 2022-03-17 US disclosed
EP-3906231-A2 NOVEL SALTS AND POLYMORPHIC FORM OF BEMPEDOIC ACID Lupin Limited (IN) 2021-11-10 EP disclosed
CN-113227061-A Novel salts and polymorphs of bipedac acid 印度鲁宾有限公司 2021-08-06 CN disclosed
WO-2020141419-A2 NOVEL SALTS AND POLYMORPHIC FORM OF BEMPEDOIC ACID LUPIN LIMITED (IN) 2020-07-09 WO disclosed
WO-2020141419-A2 NOVEL SALTS AND POLYMORPHIC FORM OF BEMPEDOIC ACID LUPIN LIMITED (IN) 2020-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220081385-A1 NOVEL SALTS AND POLYMORPHIC FORM OF BEMPEDOIC ACID HADH, ALDH5A1, ACAD9 CYP4F2 184/4885CYP4A11 197/4885GAA 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.